López-Miranda, Elena; Pérez-García, José-Manuel; Gion, María; Ribelles, Nuria; Cortez-Castedo, Patricia; Alonso-Romero, José-Luis; Martínez-García, María; González-Santiago, Santiago; Bermejo, Begoña; Morales, Serafin; Caranana, Vicente; Garrigos, Laia; Fernández-Pinto, Melissa; García-Vicente, Silvia; García-Sanz, Alicia; Mena-Molina, Arnau; Boix, Olga; Alcalá-López, Daniel; Llombart-Cussac, Antonio; Cortés, Javier
(BMC, 2025-08-06)
BACKGROUND: The PI3K/AKT pathway is frequently altered in advanced triple-negative breast cancer (aTNBC), representing a promising target. Ipatasertib, a pan-AKT inhibitor, has shown activity with taxane-based chemotherapy ...